Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gemmill

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 13, 2020
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancerAnastasios Dimou, Cecile Nasarre, Yuri K Peterson, et al.
Cancer Genetics|May 13, 2014
Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocationTakema Kato, Colleen P Franconi, Molly B Sheridan, et al.
Chest|March 1, 1996
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokersW A Franklin, S Todd, R M Gemmill, et al.
Human Molecular Genetics|February 1, 1997
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3BF Boldog, R M Gemmill, J West, et al.
Leukemia|August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sortingM Varella-Garcia, C J Hogan, L F Odom, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2003
WNT7a induces E-cadherin in lung cancer cellsTatsuo Ohira, Robert M Gemmill, Kevin Ferguson, et al.
Plos One|January 21, 2016
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerTakeshi Yoshida, Lanxi Song, Yun Bai, et al.
Cancer Research|May 19, 2006
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancerMariam Dohadwala, Seok-Chul Yang, Jie Luo, et al.
Investigational New Drugs|November 15, 2011
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combinationMichael Millward, Timothy Price, Amanda Townsend, et al.
Frontiers in Immunology|June 2, 2022
Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast CancerRajeev Dhupar, Katherine E Jones, Amy A Powers, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Thoracic and Cardiovascular Surgery|July 13, 2020
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancerAnastasios Dimou, Cecile Nasarre, Yuri K Peterson, et al.
Cancer Genetics|May 13, 2014
Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocationTakema Kato, Colleen P Franconi, Molly B Sheridan, et al.
Chest|March 1, 1996
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokersW A Franklin, S Todd, R M Gemmill, et al.
Human Molecular Genetics|February 1, 1997
Chromosome 3p14 homozygous deletions and sequence analysis of FRA3BF Boldog, R M Gemmill, J West, et al.
Leukemia|August 23, 2001
Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sortingM Varella-Garcia, C J Hogan, L F Odom, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2003
WNT7a induces E-cadherin in lung cancer cellsTatsuo Ohira, Robert M Gemmill, Kevin Ferguson, et al.
Plos One|January 21, 2016
ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerTakeshi Yoshida, Lanxi Song, Yun Bai, et al.
Cancer Research|May 19, 2006
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancerMariam Dohadwala, Seok-Chul Yang, Jie Luo, et al.
Investigational New Drugs|November 15, 2011
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combinationMichael Millward, Timothy Price, Amanda Townsend, et al.
Frontiers in Immunology|June 2, 2022
Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast CancerRajeev Dhupar, Katherine E Jones, Amy A Powers, et al.
Pageof 11